PharmAust Raises $1.3m in Rights Issue News & Announcements 2019By PharmAustMarch 22, 2019190322_Rights Issue Raises 1.3m
Monepantel Tablets Positive Performance in Phase I News & Announcements 2019By PharmAustMarch 14, 2019190314_PhaseI part A
Intellectual Property Update News & Announcements 2019By PharmAustMarch 5, 2019190305_Intellectual Property Update
Appendix 4D and Financial Report Financial Reports 2019, News & Announcements 2019By PharmAustMarch 1, 2019190301_Appendix-4D-and-Financial-Report
Top 20 Shareholders, March 1 News & Announcements 2019, Top 20 ShareholdersBy PharmAustMarch 1, 2019190301_Top_20 Shareholders March 1
Offer Document – Rights Issue News & Announcements 2019By PharmAustFebruary 25, 2019190227_Offer_Document
Phase I in Dogs Commences using New Monepantel Tablets News & Announcements 2019By PharmAustFebruary 19, 2019190220_Phase I starts
Letter to Shareholder News & Announcements 2019By PharmAustFebruary 19, 2019190219_Letter to Shareholder
Letter to Optionholder News & Announcements 2019By PharmAustFebruary 18, 2019190218_Letter to Optionholder
Section 708A Financial Reports 2019, News & Announcements 2019By PharmAustFebruary 18, 2019190218_Section 708A